% | $
Quotes you view appear here for quick access.

Pernix Therapeutics Holdings, Inc. Message Board

  • newptxholder newptxholder Apr 8, 2013 9:14 PM Flag

    Not many shares available

    % Held by Insiders1: 68.79%
    % Held by Institutions1: 26.20%

    This sets up for much bigger price swings short term

    Looking ahead
    Next quarter's average estimate for revenue is $28.3 million. On the bottom line, the average EPS estimate is -$0.05.

    Next year's average estimate for revenue is $119.7 million. The average EPS estimate is -$0.11.

    Investor sentiment

    Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Pernix Therapeutics Holdings is outperform, with an average price target of $12.40.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.9753-0.1347(-3.28%)12:10 PMEDT